24 results
8-K
EX-10.1
NEXI
Neximmune Inc
5 Feb 24
NexImmune Announces $3.67 Million
5:10pm
, state, local and foreign laws relating to pollution or protection of human health or the environment (including ambient air, surface water … , contaminants, or toxic or hazardous substances or wastes
(collectively, “Hazardous Materials”) into the environment, or otherwise relating
8-K
EX-99.1
fb6pw
15 Aug 22
NexImmune Reports Second Quarter 2022 Financial Results and Highlights FDA Clearance of IND for NEXI-003 for the Treatment of HPV-Related Cancers
4:28pm
8-K
EX-1.1
nvt74twkp569w hx55
17 Jun 22
Entry into a Material Definitive Agreement
4:51pm
DEF 14A
fju1h het9pn
3 May 22
Definitive proxy
4:16pm
10-Q
fubvqf01glfcuiv
17 May 21
Quarterly report
4:14pm
10-K
jv8xz1 hb7sb
31 Mar 21
Annual report
4:02pm
424B4
19sr4z1ueb
16 Feb 21
Prospectus supplement with pricing info
4:38pm
S-1/A
xnm3p
8 Feb 21
IPO registration (amended)
7:29am